Publication | Open Access
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
54
Citations
24
References
2021
Year
Neoadjuvant camrelizumab plus nab-paclitaxel and S1 is safe, feasible and effective in locally advanced ESCC and is worth further investigation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1